Cargando…

Analysis of Pharmaceutical Industry Payments to UK Health Care Organizations in 2015

IMPORTANCE: Drug company payments to health care organizations can create conflicts of interest. However, little is known about such financial relationships, especially outside the United States. OBJECTIVE: To examine the concentration and patterns of drug company payments to health care organizatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ozieranski, Piotr, Csanadi, Marcell, Rickard, Emily, Tchilingirian, Jordan, Mulinari, Shai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2019
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593961/ https://www.ncbi.nlm.nih.gov/pubmed/31225896 http://dx.doi.org/10.1001/jamanetworkopen.2019.6253

Ejemplares similares

Under-reported relationship: a comparative study of pharmaceutical industry and patient organisation payment disclosures in the UK (2012–2016)
por: Ozieranski, Piotr, et al.
Publicado: (2020)

Disclosure of payments by pharmaceutical companies to healthcare professionals in the UK: analysis of the Association of the British Pharmaceutical Industry’s Disclosure UK database, 2015 and 2016 cohorts
por: Mulinari, Shai, et al.
Publicado: (2018)

International comparison of pharmaceutical industry payment disclosures in the UK and Japan: implications for self-regulation, public regulation, and transparency
por: Ozieranski, Piotr, et al.
Publicado: (2023)

Pharmaceutical industry payments to NHS trusts in England: A four-year analysis of the Disclosure UK database
por: Ozieranski, Piotr, et al.
Publicado: (2023)

Exposing drug industry funding of UK patient organisations
por: Ozieranski, Piotr, et al.
Publicado: (2019)

Five years of pharmaceutical industry funding of patient organisations in Sweden: Cross-sectional study of companies, patient organisations and drugs
por: Mulinari, Shai, et al.
Publicado: (2020)

Comparing pharmaceutical company payments in the four UK countries: a cross-sectional and social network analysis
por: Rickard, Emily, et al.
Publicado: (2023)

Disclosure of Pharmaceutical Industry Funding of Patient Organisations in Nordic Countries: Can Industry Self-Regulation Deliver on its Transparency Promise?
por: Pashley, Dylan, et al.
Publicado: (2022)

A hidden web of policy influence: The pharmaceutical industry’s engagement with UK’s All-Party Parliamentary Groups
por: Rickard, Emily, et al.
Publicado: (2021)

Drug company payments to General Practices in England: Cross-sectional and social network analysis
por: Saghy, Eszter, et al.
Publicado: (2021)

Tip of the Iceberg? Country- and Company-Level Analysis of Drug Company Payments for Research and Development in Europe
por: Ozieranski, Piotr, et al.
Publicado: (2022)

Accessibility and quality of drug company disclosures of payments to healthcare professionals and organisations in 37 countries: a European policy review
por: Ozieranski, Piotr, et al.
Publicado: (2021)

Sunshine Policies and Murky Shadows in Europe: Disclosure of Pharmaceutical Industry Payments to Health Professionals in Nine European Countries
por: Fabbri, Alice, et al.
Publicado: (2018)

Misleading Advertising for Antidepressants in Sweden: A Failure of Pharmaceutical Industry Self-Regulation
por: Zetterqvist, Anna V., et al.
Publicado: (2013)

Industry Payments Received by Residents During Training
por: Hogan, Sean O., et al.
Publicado: (2023)

Payments From Pharmaceutical Companies to Authors Involved in the Valsartan Scandal in Japan
por: Sawano, Toyoaki, et al.
Publicado: (2019)

Industry Payments to Physician Specialists Who Prescribe Repository Corticotropin
por: Hartung, Daniel M., et al.
Publicado: (2018)

Evaluation of Sex Distribution of Industry Payments Among Radiation Oncologists
por: Weng, Julius K., et al.
Publicado: (2019)

US Nationwide Disclosure of Industry Payments and Public Trust in Physicians
por: Kanter, Genevieve P., et al.
Publicado: (2019)

Evaluation of Industry Payments to US Advanced Practice Clinicians in 2021
por: Singh, Armaan, et al.
Publicado: (2022)

Pharmaceutical industry payments and assisted reproduction in Australia: a retrospective observational study
por: Karanges, Emily Aspasia, et al.
Publicado: (2021)

Complaints, Complainants, and Rulings Regarding Drug Promotion in the United Kingdom and Sweden 2004–2012: A Quantitative and Qualitative Study of Pharmaceutical Industry Self-Regulation
por: Zetterqvist, Anna V., et al.
Publicado: (2015)

Pharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003–2012
por: Vilhelmsson, Andreas, et al.
Publicado: (2016)

Assessment of Pharmaceutical Company and Device Manufacturer Payments to Gastroenterologists and Their Participation in Clinical Practice Guideline Panels
por: Nusrat, Salman, et al.
Publicado: (2018)

Pharmaceutical lobbying and pandemic stockpiling of Tamiflu: a qualitative study of arguments and tactics
por: Vilhelmsson, Andreas, et al.
Publicado: (2018)

Trends in Dialysis Industry Consolidation After Medicare Payment Reform, 2006-2016
por: Sloan, Caroline E., et al.
Publicado: (2021)

Nature and Trends in Personal Payments Made to the Respiratory Physicians by Pharmaceutical Companies in Japan between 2016 and 2019
por: Murayama, Anju, et al.
Publicado: (2022)

Trends in Industry Payments to Physicians in the First 6 Years After Graduate Medical Training
por: Han, Misop, et al.
Publicado: (2022)

Association of Patient Outcomes With Bundled Payments Among Hospitalized Patients Attributed to Accountable Care Organizations
por: Navathe, Amol S., et al.
Publicado: (2021)

Evaluation of Pharmaceutical Company Payments and Conflict of Interest Disclosures Among Oncology Clinical Practice Guideline Authors in Japan
por: Saito, Hiroaki, et al.
Publicado: (2019)

Association Between Open Payments–Reported Industry Transfers of Value and Prostaglandin Analog Prescribing in the US
por: Nguyen, Andrew M., et al.
Publicado: (2022)

Association of Bundled Payments for Joint Replacement Surgery and Patient Outcomes With Simultaneous Hospital Participation in Accountable Care Organizations
por: Liao, Joshua M., et al.
Publicado: (2019)

Assessment of Immigrants’ Premium and Tax Payments for Health Care and the Costs of Their Care
por: Ommerborn, Mark J., et al.
Publicado: (2022)

Association of Hospital Interoperable Data Sharing With Alternative Payment Model Participation
por: Holmgren, A Jay, et al.
Publicado: (2022)

Association between physician characteristics and payments from industry in 2015–2017: observational study
por: Inoue, Kosuke, et al.
Publicado: (2019)

Pension payment dates in 2015
Publicado: (2014)

Primary care capitation payments in the UK. An observational study
por: Rhys, Gwion, et al.
Publicado: (2010)

Facial plating industry payments: An analysis of the open payments database
por: Lorenz, F. Jeffrey, et al.
Publicado: (2023)

Medicare Beneficiaries’ Perspectives on the Quality of Hospital Care and Their Implications for Value-Based Payment
por: Trenaman, Logan, et al.
Publicado: (2023)

Medicaid Value-Based Payments and Health Care Use for Patients With Mental Illness
por: Lewis, Ashley, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ifvtm31vjeln2nlp98c97860di